Title |
Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder
|
---|---|
Published in |
ClinicoEconomics and Outcomes Research: CEOR, March 2011
|
DOI | 10.2147/ceor.s17846 |
Pubmed ID | |
Authors |
Xianchen Liu, Yi Chen, Douglas E Faries |
Abstract |
THIS STUDY COMPARED ADHERENCE AND PERSISTENCE OF THREE BRANDED ANTIDEPRESSANTS: the serotonin and norepinephrine reuptake inhibitors (SNRIs) duloxetine and venlafaxine XR, and the selective serotonin reuptake inhibitor (SSRI) escitalopram; and generic selective SSRIs, and examined demographic and clinical predictors of adherence and persistence in patients with major depressive disorder in usual care settings. |
Mendeley readers
The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
India | 1 | 2% |
Unknown | 55 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 11 | 20% |
Researcher | 9 | 16% |
Student > Bachelor | 7 | 13% |
Student > Ph. D. Student | 6 | 11% |
Student > Postgraduate | 6 | 11% |
Other | 13 | 23% |
Unknown | 4 | 7% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 23 | 41% |
Nursing and Health Professions | 7 | 13% |
Psychology | 4 | 7% |
Biochemistry, Genetics and Molecular Biology | 3 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 5% |
Other | 10 | 18% |
Unknown | 6 | 11% |